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Although some data link archaeal and eukaryotic translation, the overall mechanism of protein syn-
thesis in archaea remains largely obscure. Both archaeal (aRF1) and eukaryotic (eRF1) single release
factors recognize all three stop codons. The archaeal genus Methanosarcinaceae contains two aRF1
homologs, and also uses the UAG stop to encode the 22nd amino acid, pyrrolysine. Here we provide
an analysis of the last stage of archaeal translation in pyrrolysine-utilizing species. We demon-
strated that only one of two Methanosarcina barkeri aRF1 homologs possesses activity and recog-
nizes all three stop codons. The second aRF1 homolog may have another unknown function. The
mechanism of pyrrolysine incorporation in the Methanosarcinaceae is discussed.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
At the ﬁnal stage of protein biosynthesis the class-1 release fac-
tors (RF1s) recognize stop codons and induce hydrolysis of pepti-
dyl-tRNA in the peptidyl transferase center of the ribosome
(reviewed in [1–3]). In eukaryotes a single release factor (eRF1)
recognizes all three stop codons, UAA, UAG and UGA. Bacteria have
two release factors (RF1 and RF2) that recognize different stop-co-
don pairs, UAA/UAG and UAA/UGA, respectively. Archaeal class-1
release factors (aRF1s) exhibit a high degree of amino acid se-
quence similarity with eRF1s and are substantially different from
bacterial RFs (Fig. 1). Like eRF1, aRF1 recognizes all three stop co-
dons [4], demonstrating the functional resemblance of aRF1 and
eRF1. Thus, archaeal translation termination has common features
with eukaryotic termination and their mechanisms are expected to
be similar. Most archaea contain only one gene encoding aRF1, but
in two species of pyrrolysine (Pyl)-utilizing archaea, Methanosarci-
na barkeri andMethanosarcina acetivorans, two non-identical class-
1 translation termination factors were found (aRF1-1 and aRF1-2),chemical Societies. Published by Ewhile the other Pyl-containing archaea, Methanosarcina mazei and
Methanococcoides burtonii, have only one aRF1 [5].
An in-frame UAG codon has been identiﬁed in mtmB1 encoding
MtmB1, a methylamine methyltransferase participating in metha-
nogenesis from monomethylamine in M. barkeri (reviewed in [6]).
The UAG is translated by the novel amino acid Pyl as revealed by
the crystal structure of MtmB1 [7]. An in-frame UAG codon is also
contained in mtbB1 and mttB1, the genes encoding the di- and tri-
methylamine methyltransferases inMethanosarcina spp. (reviewed
in [6]), as well as in a number of other open reading frames [8,9].
Examination of the presently sequenced genomes suggests that
the existence of Pyl is limited to the Methanosarcinaceae (Methan-
osarcina spp. and M. burtonii) and to a few bacteria (Desulﬁtobacte-
rium hafniense [10] and symbiotic d-proteobacteria [9,11]).
Pyl is co-translationally inserted at UAG codons and as such
constitutes the 22nd natural amino acid used in protein synthesis.
Pyl has its own tRNAPyl whose CUA anticodon complements the
UAG codon [10], and a special aminoacyl-tRNA synthetase (PylRS)
that speciﬁcally acylates tRNAPyl to form Pyl-tRNAPyl [12,13]. While
the molecular principles governing the synthesis of Pyl-tRNAPyl
have been worked out in details, the mechanism underlying the
recoding of the UGA codon as Pyl sense codon remains poorly
understood. Pyl share with selenocysteine (Sec) the property of
being inserted at in-frame stop codons (UGA for Sec). Selenocys-lsevier B.V. All rights reserved.
Fig. 1. Multiple sequence alignment of the N-terminal domains of release factors from different archaea, eukaryotes and bacteria.
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For Sec, a RNA stem loop (termed SECIS element) located in the
mRNA signals the UGA codon to be recoded to the translation
machinery. In addition, an essential tRNASec-speciﬁc elongation
factor (SelB or EFSec) delivers the Sec-tRNASec at the suppression
site, ensuring the successful translation of the in-frame UGA codon
as selenocysteine [14–17].
While it was initially thought that Pyl insertion mechanism
could be modeled on that of Sec, recent data suggest otherwise.
A stem loop structure analogous to the SECIS element (and thus
termed PYLIS element) was predicted downstream of the in-frame
UAG codon in mtmB1 mRNAs [18,19]. However, in contrast to Sec,
the presence of the RNA stem loop structure was not critical for the
insertion of Pyl into proteins. The PYLIS structure moderately mod-
ulated MtmB1 expression inMethanosarcina and did not impact re-
porter protein expression in an Escherichia coli context [20,21].
Sequence comparison studies showed that PYLIS structure is not
conserved in the mtbB1 and mttB1 mRNAs. Lastly, in vitro and
in vivo experiments in E. coli demonstrated that elongation factor
Tu is capable of interacting and delivering Pyl-tRNAPyl to the UGA
suppression site, suggesting that no specialized elongation factor
is required for Pyl insertion [22].
In order to gain further insight into UAG recoding mechanism,
we have determined stop codon speciﬁcity of two M. barkeri
aRF1 homologs in an in vitro reconstituted eukaryotic translation
system. For these purposes we constructed chimeric proteins
which contain the N-terminal domain of M. barkeri aRF1s (respon-
sible for stop-codon decoding) and the MC domains of human eRF1
since the full-length aRF1s from this organism are unable to inter-
act with eukaryotic ribosomes used in translation termination as-
say. We have shown that only one out of two forms of M. barkeri
aRF1s is active in translation termination and recognizes all three
stop codons. Taking into account that the frequency of UAG stop-
codon usage is substantially decreased in Pyl-encoding genomes,
our data suggest that the Methanosarcinaceae may be in a contin-
uing process of the UAG codon reassignment from a stop signal
to a sense codon specifying Pyl.
2. Materials and methods
2.1. M. barkeri and Methanococcus maripaludis aRF1 gene constructs
M. barkeriwild-type aRF1-1 and aRF1-2 genes were ampliﬁed by
PCR using freshly prepared genomic DNA. PCR products were
cloned in Topo TA (Invitrogen), sequenced and subcloned into
pET15b expression plasmid between BamHI and PstI restrictionsites.M. maripaludis aRF1 gene was cloned following the same pro-
cedure and subcloned in pET15b between NdeI and XhoI sites.
2.2. Chimeric archaeal/human release factor constructs
The aRF1 gene sequences encoding the N domains of M. barkeri
aRF1-1 and aRF1-2 and M. maripaludis aRF1 were PCR-ampliﬁed
using speciﬁc primers. The ﬁrst primer contained an NdeI site and
the second one carried a SalI site in putative boundary of the N and
M domains of aRF1 (codons for amino acids 144 and 145, numbered
according to human eRF1). The determination of the putative bound-
aries between theN andMdomains of aRF1swas based on the crystal
structure of human eRF1 [23] and amultiple alignment of protein se-
quences of archaeal and human release factors. The resulting PCR
productswere inserted intoNdeI/SalI sites of the pERF4b-Sal plasmid.
pERF4b-Sal plasmid with cloned eRF1 gene from Homo sapiens in-
serted into SalI restriction site of pET23b(+) vector (Novagen) was
constructed previously [24]. Thus, three plasmids carrying chimeric
genes encoding the archaeal N domain of aRF1s and MC domain of
human eRF1with 6His-tag on the C-terminuswere obtained.Mutant
forms carrying the N domain of M. barkeri aRF1-2 with amino acid
substitutions corresponding to the amino acid sequence ofM. barkeri
aRF1-1 (K61N or D122V + I124K or D122T + Y123F + I124V; amino
acid numbering according to human eRF1) were obtained by PCR
mutagenesis as described [25].
2.3. Proteins and ribosomal subunits
The 40S and 60S ribosomal subunits, eIF2, eIF3, eIF4F, eEF1H
and eEF2 were puriﬁed from rabbit reticulocyte lysate as described
(see references in [26]). The eukaryotic translation factors eIF1,
eIF1A, eIF4A, eIF4B, eIF5B, eIF5, eRF1, chimeric a/eRF1 were pro-
duced as recombinant proteins in E. coli strain BL21 with subse-
quent protein puriﬁcation on Ni-NTA-agarose and ion-exchange
chromatography (see references in [26]).
2.4. mRNA transcripts
mRNA was transcribed by T7 RNA polymerase on MVHL-stop
plasmids, encoding T7 promoter, four CAA repeats, b-globin 50-
untranslated region (UTR), MVHL tetrapeptide followed by one of
three stop codons (UAA, UAG or UGA) and 30-UTR comprising the rest
of the natural b-globin coding sequence.MVHL-UAAplasmidwas de-
scribed [26], andMVHL constructs containing UAG and UGA stop co-
dons were obtained by PCR mutagenesis of MVHL-UAA plasmid. For
run-off transcription all plasmids were linearized with XhoI.
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Total calf liver tRNA (Novagen) was puriﬁed by size-exclusion
chromatography on a Superdex 75 HR column (GE Healthcare) to
remove high and low molecular weight contaminants. tRNAMeti
was aminoacylated by methionine using E. coli methionyl-tRNA
synthetase as described [26]. The aminoacylation reaction mixture
contained 40 mM Tris–acetate, pH 7.5, 10 mM Mg(OAc)2, 4 mM
ATP, 0.2 mM L-methionine, 14 KBq/ll [35S]methionine (GE Health-
care), 0.25 mAU280nm/ll puriﬁed E. colimethionyl-tRNA synthetase,
0.8 u/ll RNAse inhibitor (RiboLock, Fermentas) and 6–10 lg/ml of
puriﬁed total calf liver tRNA. Reaction was run for 25 min at 37 C.
2.6. Pretermination complex assembly and puriﬁcation
Pretermination complexes were assembled as described [26].
Brieﬂy, 37 pmol of MVHL-stop mRNAs were incubated in buffer A
(20 mM Tris–acetate, pH 7.5, 100 mM KAc, 2.5 mM MgCl2, 2 mM
DTT) supplemented with 400 u RNAse inhibitor (RiboLock, Fer-
mentas), 1 mM ATP, 0.25 mM spermidine, 0.2 mM GTP, 75 lg total
tRNA (acylated with Val, His, Leu and [35S]Met), 75 pmol 40S and
60S puriﬁed ribosomal subunits, 125 pmol eIF2, eIF3, eIF4F, eIF4A,
eIF4B, eIF1, eIF1A, eIF5, eIF5B each, 200 pmol eEF1H and 50 pmol
eEF2 for 30 min and then centrifuged in a Beckman SW55 rotor
for 95 min at 4 C and 50 000 rpm in 10–30% linear sucrose density
gradient prepared in buffer A with 5 mM MgCl2. Fractions corre-
sponded to pretermination complexes according to optical density
and the presence of [35S]Met were combined, diluted 3-fold with
buffer A containing 1.25 mM MgCl2 (to a ﬁnal concentration of
2.5 mM Mg2+) and used for peptide release assay.
2.7. Peptide release assay
Peptide release assay was run as described [26] with somemod-
iﬁcations. Aliquots containing 0.1 pmol of pretermination com-
plexes with an activity of about 10 000 cpm assembled in the
presence of [35S]Met-tRNA were incubated at 37 C for 15 min with
different concentrations of release factors (0–120 pmol). Ribo-
somes and tRNA were pelleted with ice-cold 5% TCA supplemented
with 0.75% casamino acids and centrifuged at 4 C and 14 000g.
The amount of released [35S]Met-containing tetrapeptide, which
indicated the efﬁciency of peptidyl-tRNA hydrolysis, was deter-
mined by scintillation counting of supernatants on an Intertech-
nique SL-30 liquid scintillation spectrometer.
2.8. Sequence analysis
Nucleotide sequences of aRF1 genes were downloaded from the
GenBank database (NCBI, NIH). Phylogenetic analysis was done by
MEGA package version 4.0 [27]. Phylogenetic tree of aRF1s was
constructed by neighbor-joining method using codon-based evolu-
tionary divergence between sequences using HYK85 as imple-
mented in MrBayes [28]. To compare gene pairs and to calculate
synonymous and non-synonymous substitutions MUSCLE align-
ment with default parameters was used [29].3. Results
3.1. Peptide release activity of the chimeric M. barkeri and M.
maripaludis a/eRF1 proteins and the full-length Methanococcus
jannaschii aRF1
The activity and codon speciﬁcity of the two M. barkeri release
factors homologs, aRF1-1 and aRF1-2 were measured in vitro using
a fully reconstituted eukaryotic translation system, aminoacylatedtRNA and model mRNAs encoding for the MVHL peptide [26]. The
coding region of the model mRNAs was terminated by one of the
three stop codons (UAA, UGA and UAG). The activity of each release
factor was directly measured by the amount of free 35S-labeled
MVHL generated [26]. As controls M. maripaludis and M. jannaschii
aRF1s of non-Pyl-utilizing archaea were used.
The M. barkeri and M. maripaludis aRF1s turned out to be inac-
tive with any stop codon in the test system probably due to their
inability to interact with eukaryotic ribosomal complexes (data
not shown). However, the M. jannaschii aRF1 was able to induce
peptide release in the presence of all three stop codons (Fig. 2).
In eukaryotes, the N-terminal domain of eRF1 is implicated in
the decoding of stop codons as shown by genetic [30] and bio-
chemical [31–33] data. To overcome the lack of interaction of the
M. barkeri and M. maripaludis aRF1s with heterologous rabbit ribo-
somes we constructed chimeric proteins (a/eRF1s) which consisted
of the N-terminal domains of aRF1s and the C-terminal part (M and
C domains) of human eRF1. These chimeras were designed so that
they should have stop codon speciﬁcity of the aRF1s and stop-co-
don-independent ribosome binding properties of human eRF1. This
approach has been already successfully used to determine the
decoding properties of eRF1s from different species of ciliates
[24]. Using this method, we show that only one of the two forms
ofM. barkeri a/eRF1s, a/eRF1-1 induces peptide release in the pres-
ence of all three stop codons, while a/eRF1-2 is inactive with any of
the three stop codons (Fig. 2).
We noticed that M. barkeri a/eRF1-1 displays reduced peptide
release efﬁciency when UAG is used as stop codon compared to
UAA or UGA. This stop codon preference pattern was also observed
for theM. jannaschii aRF1 control, since with this release factor too,
UAG stop codon triggered a weaker peptide release activity. M.
maripaludis a/eRF1 displayed a different pattern of stop codon pref-
erence since the release factor was signiﬁcantly more active with
UAA stop codons than with UGA or UAG. Interestingly, M. marip-
aludis a/eRF1 had a much stronger release activity than itsM. bark-
eri a/eRF1-1 and M. jannaschii aRF1 counterparts when UAA was
used as stop codon.
Alignment of aRF1 sequences (Fig. 1) revealed amino acid sub-
stitutions in positions 61 (NIKS motif) and 122–124 (near YxCxxF
motif) of non-active M. barkeri aRF1-2 (numeration of amino acids
according to human eRF1). These positions have been shown to be
essential for eRF1 stop-codon recognition [31,34]. To clarify the
inﬂuence of these amino acids on decoding activity, three mutants
of M. barkeri a/eRF1-2 were constructed with the following amino
acid substitutions in the N domain: K61N, D122V + I124K or
D122T + Y123F + I124V corresponding to a/eRF1-1 amino acid se-
quence. However, like their wild-type a/eRF1-2 counterpart, these
a/eRF1-2 mutants do not recognize stop codons (data not shown).
3.2. Phylogenetic analysis of the release factors from the
Methanosarcinaceae family
Comparison of coding sequences of aRF1 genes from the Met-
hanosarcinaceae family revealed two observations: (i) higher pair-
wise similarity between aRF1-1s of M. barkeri and M. acetivorans
and, as well, between aRF1-2s ofM. barkeri andM. acetivorans than
between aRF1-1 and aRF1-2 within same species and (ii) M. mazei
aRF1 belongs to the same phylogenetic clade as M. barkeri and M.
acetivorans aRF1-1s (Fig. 3). These results conﬁrm the species phy-
logenetic tree constructed by Zhang et al. [5]. It also suggests that
the duplication of aRF1 gene in genusMethanosarcina occurred be-
fore the divergence of M. acetivorans, M. barkeri and M. mazei spe-
cies. According to this evolutionary scenario M. acetivorans and M.
barkeri retained their aRF1-2 while M. mazei genome lost its copy.
Quantitative comparison of gene copies was provided by calcu-
lating the ratio of synonymous and non-synonymous substitutions
Fig. 2. Release activity of aRF1s from Pyl-utilizing and non-Pyl-utilizing archaea in a reconstituted eukaryotic translation system. Filled circles – activity in the presence of
UAA stop codon; empty circles – activity in the presence of UAG stop codon; ﬁlled triangles – activity in the presence of UGA stop codon.
Table 1
The number of amino acid substitutions in M. acetivorans and M. barkeri aRF1s
compared to M. mazei aRF1.
Syn/non-syn
M. acetivorans aRF1-1 136/27
M. barkeri aRF1-1 168/51
M. acetivorans aRF1-2 161/222
M. barkeri aRF1-2 159/221
The ﬁrst and the second numbers in each cell are the quantity of synonymous and
non-synonymous amino acid substitutions, respectively.
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sequence (Table 1). Notably, the number of non-synonymousFig. 3. Phylogenetic tree of aRF1 genes from Methanosarcinaceae, Pyl-utilizingsubstitutions in the aRF1-2 forms is higher than in aRF1-1 but this
gene still appears to be under negative selection with a relative
synonymous/non-synonymous ratio (dn/ds) < 1. Both the M. bark-
eri and M. acetivorans copies of aRF1-2 genes lack nonsense or
frameshift mutations which indicate that the corresponding gene
products retained or gained some physiological role.
3.3. Methanosarcinales genome analysis
It has been shown that UAG is a rare codon in Methanosarcina-
ceae genomes (less than 5% of all three stop codons compared to
UAA and UGA, approximately 45% each) [5]. Using the two direc-
tional best BLAST hit approach [35] we have performed a detailed
analysis of the stop codon usage in orthologous genes of the orderarchaeal family, and M. maripaludis aRF1, a non-Pyl-utilizing organism.
Table 2
Stop codon usage for orthologous genes in the Methanosarcinaceae family in
comparison with analogous data for Methanosaeta thermophila/order
Methanosarcinales.
UAA UAG UGA
Methanosarcinaceae
M. acetivorans 416 7 415
M. mazei 445 8 385
M. barkeri 505 9 324
M. burtonii 401 6 431
Methanosaetaceae
M. thermophila 107 160 571
E. Alkalaeva et al. / FEBS Letters 583 (2009) 3455–3460 3459Methanosarcinales. We detected orthologs in four genomes of the
Pyl-utilizing archaea in the Methanosarcinaceae family and in one
outgroup genome of a non-Pyl-utilizing Methanosaetaceae (Meth-
anosaeta thermophila). While UAG was found in 6–9 orthologous
genes in the Methanosarcinaceae, the same codon was found in
160 orthologous genes in the outgroup organism M. thermophila
(Table 2). Thus, comparison of stop codon usage in orthologs
clearly demonstrates avoidance of UAG stop codon in Pyl-utilizing
archaea. It is reasonable to speculate that the majority of UAG co-
dons were changed to UAA stop codons. Indeed the UAG to UAA
conversion requires only one substitution and is evolutionary more
favorable than the UAG to UGA conversion which requires two
nucleotide substitutions. This notion is supported by the fact that
ﬁrst, UAA is used as stop codon in 401–505 orthologs in the Met-
hanosarcinaceae while it is present in only 107 orthologs in the
non-Pyl usingM. thermophila genome, and second, that the number
of orthologs using UGA remains comparable in the Methanosarcin-
aceae and in M. thermophila (324/431 vs 571, Table 2). Notably,
without ortholog analysis we cannot observe UAG stop-codon
avoidance. On the whole genome level, taking into consideration
poorly conserved and ‘‘newest” (i.e. duplicated, horizontally trans-
ferred) genes, UAG is occurred substantially more often, for exam-
ple, among 3370 genes of M. mazei UAG is used only 125 times.
4. Discussion
4.1. Archaeal release factors are omnipotent
Our data show that archaeal release factors, whether in their
native form (M. jannaschii) or as archaeal/eukaryotic chimeras
(M. maripaludis and M. barkeri) stimulate hydrolysis of peptidyl-
tRNA in a reconstituted eukaryotic translation system and respond
to all three stop codons. These data imply that mechanisms of
translation termination in eukaryotes and archaea are similar.
The comparison of aRF1-1 from M. jannaschii and M. barkeri sug-
gests that termination mechanism is likely to be similar inMethan-
osarcinaceae and in other non-Pyl-containing archaea.
The role of the second release factor encoded in the M. barkeri
and M. acetivorans genome is not known, as this aRF1-2 protein
(signiﬁcantly diverged from the aRF1-1 sequence) is inactive in
translation termination. It is pertinent to mention that theM. bark-
eri genome has two other examples of duplicated translation-re-
lated genes; there are two evolutionarily unrelated seryl-tRNA
synthetases [36] and lysyl-tRNA synthetases [37].
4.2. Is UAG recoded for Pyl insertion?
The above results now provide the context for a discussion of
UAG-directed Pyl incorporation. There are several ways by which
UAG could be used as designating Pyl. (i) The ﬁrst scenario would
be similar to Sec, where an intricately executed scheme of recoding
is operative involving an RNA structure (the SECIS element) located
in the mRNA and a special elongation factor (SelB). This may not behappening for Pyl, as the initial excitement of the PYLIS RNA ele-
ments [18] could not be experimentally supported [5], and a new
elongation factor was not required for Pyl-tRNA binding [19] or
in vivo incorporation [20,21]. (ii) In some organisms stop codons
are completely reassigned to a given amino acid; this is mediated
by an adjustment of release factor speciﬁcity. In Tetrahymena ther-
mophila, where the UAG and UAA codons are recoded as glutamine,
the eRF1 only recognizes UGA as stop codon [38]. Similarly, in the
ciliate Euplotes aediculatus UGA codon is reassigned to cysteine. In
this organism eRF1 has restricted its speciﬁcity to UAA and UGA
and lost its ability to trigger release at UGA codons [39]. However,
as shown above,Methanosarcina aRF1 is omnipotent; thus this sce-
nario is not operative either. Therefore, as in the case of nonsense
suppression [40], Pyl insertion most likely results from simple
competition between a suppressor aminoacyl-tRNA (in this case
Pyl-tRNAPyl) and a release factor (in this case aRF1-1) at ambiguous
UAG codons. Early termination results in truncated proteins that
are easily disposed off by the protein degradation machinery. On
the other hand, the risk of undesired readthrough of a UAG codon,
that is designed to be a stop signal, is often minimized by occur-
rence of UAA or UGA codons located a short distance downstream
of the UAG stop codon [5]. Thus, successful expansion of the genet-
ic code by reassigning a stop codon to a new amino acid (e.g., Pyl) is
not dependent on a precise recoding mechanism.
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